THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY;National Research Council of Canada
发明人:
BERNARD MASSIE,PNINA BRODT,TRAIAN SULEA
申请号：
BR112014014418
公开号：
BR112014014418A2
申请日:
2012.12.14
申请国别(地区):
BR
年份:
2019
代理人:
摘要：
abstract: title soluble igf receptor fc fusion proteins and uses thereof are described herein novel soluble igf receptor fc fusion proteins and compositions and methods of use thereof for treating angiogenesis associated disorders and malignant disease, such as cancer and metastasis, wherein the fusion proteins bind specifically to igf-1 or igf-2. soluble igf receptor fc fusion proteins and uses thereof Described herein are novel soluble igf receptor fc fusion proteins and compositions and methods of using them to treat angiogenesis associated disorders, such as cancer and metastasis, wherein fusion proteins specifically bind to igf-1 or igf-2.abstract: title soluble igf receptor fc fusion proteins and uses thereof there are described herein novel soluble igf receptor fc fusion proteins and compositions and methods of use thereof for treating angiogenesis associated disorders and malignant disease, such as cancer and metastasis, wherein the fusion proteins bind specifically to igf-1 or igf-2. _______________________________________________________________________________ tradução resumo proteínas de fusão fc de receptor igf solúvel e usos das mesmas são descritos aqui novas proteínas de fusão fc de receptor igf solúveis e composições e métodos de uso das mesmas para tratar distúrbios associados a angiogênese, tal como câncer e metástase, em que as proteínas de fusão se ligam especificamente a igf-1 ou igf-2.
